Migergot

   
Google
 
Web NewDrugInformation.com

Migergot


Drug - Migergot
The trade name of the product as shown on the labeling.

Dosage - SUPPOSITORY; RECTAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Caffeine; Ergotamine Tartrate
Multiple ingredients are in alphabetical order.

Strength - 100MG;2MG
The potency of the active ingredient(s), Caffeine; Ergotamine Tartrate. May repeat for multiple part products.

Applicant - G AND W LABS
The firm name holding legal responsibility for Migergot. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 086557
The FDA assigned number to Migergot. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Migergot. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - BR
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 4, 1983
The date Migergot was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Migergot. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Migergot is in. Format is RX, OTC, DISCN.

Applicant Full Name - G And W Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Migergot.

Migergot